Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023
Operating Activities
Net income (loss)	$ (167,187)	$ 35,271
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation of property and equipment	19,302	18,992
Amortization of other intangible assets	17,596	19,162
Amortization of debt issuance costs	0	960
Stock-based compensation expense	45,358	37,167
Equity-method loss	0	1,150
Deferred income taxes	29,100	(5,881)
Changes in operating assets and liabilities:
Accounts receivable	(19,585)	(30,706)
Inventories	54,724	(66,971)
Prepaid expenses and other assets	23,091	8,085
Accounts payable	(13,849)	(37,039)
Other current liabilities and income taxes	(5,004)	(39,155)
Deferred revenue and returns liability	6,361	3,286
Other non-current liabilities	(13,946)	6,794
Net cash used in operating activities	(24,039)	(48,885)
Investing Activities
Purchases of marketable securities	(28,363)	(91,493)
Sales of marketable securities	44,057	365,073
Maturities of marketable securities	131,008	171,766
Purchases of property and equipment	(7,785)	(18,533)
Proceeds from sale of equity investment	12,382	0
Purchases of other assets	0	(395)
Net cash provided by investing activities	151,299	426,418
Financing Activities
Proceeds from revolving line of credit	0	80,000
Payments on debt	(45,000)	(571,157)
Repurchases of common stock	0	(217,137)
Payment of taxes withheld for vested stock awards	(16,078)	(17,239)
Proceeds from the issuance of common stock	9,396	8,013
Net cash used in financing activities	(51,682)	(717,520)
Increase (decrease) in cash and cash equivalents	75,578	(339,987)
Cash and cash equivalents at beginning of period	227,504	499,915
Cash and cash equivalents at end of period	$ 303,082	$ 159,928